Name of Student Nurse: Date: December 17, 2021

Level/block/group: Hospital/Area: Clinical Instructor:

NAME OF DRUG MECHANISM OF ACTION CONTRAINDICATIONS SIDE EFFECTS ADVERSE EFFECTS NURSING RESPONSIBILITIES
GENERIC NAME Nifedipine (Adalat) inhibits calcium  Hypersensitivity to CNS: dizziness. CNS: headache, light-  Assess for anginal pain,
Nifedipine ion movement across cell membranes Nifedipine. Headache, drowsiness. headedness, fatigue including location, intensity,
of vascular smooth muscle and  ST elevation Tremor duration, and alleviating and
myocardium effect. The therapeutic myocardial CV: hypotension, aggravating.
BRAND NAME effect of this drug is, it relaxes infarction (STEMI). CV: palpitations, bradycardia, peripheral  Concurrent therapy with
Adalat CC, Adalat XL, coronary vascular smooth muscle and  Patient with blood tachycardia edema, heart block sublingual nitroglycerin may
Afeditab CR, Procardia, coronary vasodilation, increases pressure of less than be used for relief of anginal
Procardia XL myocardial oxygen delivery (angina), 90 mmHg (severe GI: nausea. Diarrhea, GI: nausea, hepatic injury pain.
reduces peripheral vascular resistance, hypotension). constipation, abdominal  Record onset type (sharp,
CLASSIFICATION and reduces arterial blood pressure  Contraindicated in discomfort EENT: rash, skin dull, squeezing), radiation,
Pharmacotherapeutic: patient with known flushing location, intensity, duration o
calcium-channel serious GU: increased urine anginal pain; precipitating
blocker, dihydropyridine output factors (exertion. Emotional
dihydropyridine hypersensitivity. stress).
 Nifedipine should Others: urticaria, eye  Check B/P for hypertension
Clinical: be use cautiously in pain, visual immediately before giving
Antianginal, patient with severe disturbances, nasal medication.
antihypertensive bradycardia and in congestion  Assess for cardiac status with
patient with B/P, pulse, respiration, and
INDICATION congestive heart ECG.
Nifedipine (Adalat) failure because  Monitor potassium and liver
capsules are indicated nifedipine can function throughout treatment
to treat vasospastic precipitate or of nifedipine.
angina and chronic exacerbate heart  Assist with ambulation if
stable angina. failure due to its light-headedness, dizziness
Extended-release negative inotropic occurs.
tablets are indicated to effects, particularly  Assess for peripheral edema.
treat vasospastic in patients receiving  Assess skin for flushing.
angina. Chronic stable
 angina and concomitant beta-  Observe for signs/symptoms
hypertension. blocker therapy. of Heart Failure.
 Nifedipine should
be avoided in PATIENT/FAMILY TEACHING
DOSAGE & patients with aortic  Instruct the patient to stand
FREQUENCY stenosis because the slowly from lying as
PRIZENTAL’S drug can worsen the orthostatic hypotension can
VARIANT ANGINA, abnormal pressure occur.
CHRONIC STABLE gradient associated  Explain the use and
(EFFORT with this condition. administration of drugs to the
ASSOCIATED)  Pregnancy and family.
ANGINA Lactation. Can  Instruct the patient to report
PO: (Immediate- cause potential palpitations, shortness of
Release) adverse effect to the breath, pronounced dizziness,
ADULTS, ELDERLY: fetus and should not nausea, exacerbations of
initially, 10 mg 3 times a be used unless the angina.
day. Increase at 7-to 14- benefit to the  Remind the patient to avoid
day intervals. mother clearly alcohol, contaminant
MAINTENANCE: 10 outweighs the risk grapefruit product use.
mg 3 times/day up to 30 to the fetus.  Instruct the patient to avoid
mg 4 times/day.  This drug should dangerous activities until
MAXIMUM: 180 not be use in a stabilized on the medicine or
mg/day patient with renal dizziness is not present.
PO: (extended release): and hepatic
ADULTS, ELDERLY: impairment because
initially 30-60 mg/day. this can alter
May increase at 7-to 14- metabolism and
day intervals. excretion of drugs
MAXIMUM: 120 which can increase
mg/day risk for toxicity.
HYPERTENSION
PO: (extended release)
ADULTS, ELDERLY:
initially, 30-60 mg/day.
May increase at 7-to 14-
day intervals.
MAXIMUM: 90-120
mg/day.
CHILDREN 1-17 YRS:
initially, 0.2-0.5
mg/kg/day.
MAXIMUM: 3
mg/kg/day or 120
mg/day.